Axios: “Pelosi’s proposal would direct the federal government to negotiate the price of certain expensive drugs with little or no competition — and, crucially, that would also become the price in the private market, not just the Medicare drug coverage price, according to Democratic aides and lobbyists working on the issue. That’s awfully close to what Trump has endorsed before, but Democrats aren’t eager to share the issue ahead of 2020.”
“People following the legislative debate suspect that normal partisan politics will likely take control over this particular plan — ‘except if the president is for it. That will change everything,’ an industry lobbyist said.”
Save to Favorites